For patients with de-novo metastatic disease, 10 patients (10/13, 77%) underwent [68Ga]Ga-PSMA-11, while 3 patients (3/13, 23%) underwent [18F]F-PSMA-1007 in this subgroup. The gene discussed is FOLH1; the disease is metastatic neoplasm.